The following is taken from the section, "How should treatment be given", from the peer-reviewed medical-journal article, "The Many Faces of Cobalamin (Vitamin B12) Deficiency": [Start quote] For parenteral therapy in cases of megaloblastic anemia, it has been advised to administer 1000 mg hydroxocobalamin IM twice weekly for a period of 5 weeks, and the dose is reduced to 1000 mg IM every 2 months thereafter
Factors That May Affect Your Starting Dose Starting dose and escalation speed are influenced by BMI, renal and hepatic function, gastrointestinal history, concomitant glucose-lowering medications, and age
Frequently Asked Questions What is peptide therapy
PeptidePanel is the neutral tracking layer for that it records the protocol your clinician sets, charts your bloodwork against reference ranges, and reminds you when a dose or a lab is due
Experimental investigations have explored its effects in models involving body composition, metabolic health, and cellular energy balance
